Attachment 1 - Relevant page from the current Electronic Edition of the Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) for INVANZ

The eRulemaking Program published this content on July 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 07, 2026 at 20:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]